Bolt Biotherapeutics Inc (BOLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,745 | -19,601 | -11,040 | -63,118 | -47,182 |
| Depreciation Amortization | 527 | 367 | 190 | -834 | -952 |
| Other Working Capital | -5,233 | -3,351 | -2,511 | -4,883 | -2,185 |
| Other Operating Activity | -1,243 | -377 | -4 | 7,546 | 3,460 |
| Operating Cash Flow | $-32,694 | $-22,962 | $-13,365 | $-61,289 | $-46,859 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 42,337 | 24,381 | 13,588 | 57,469 | 45,237 |
| PPE Investments | 891 | 963 | 963 | 107 | 107 |
| Investing Cash Flow | $43,228 | $25,344 | $14,551 | $57,576 | $45,344 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 14 | 14 | N/A | 108 | 79 |
| Financing Cash Flow | $14 | $14 | $N/A | $108 | $79 |
| Beginning Cash Position | 8,970 | 8,970 | 8,970 | 12,575 | 12,575 |
| End Cash Position | 19,518 | 11,366 | 10,156 | 8,970 | 11,139 |
| Net Cash Flow | $10,548 | $2,396 | $1,186 | $-3,605 | $-1,436 |
| Free Cash Flow | |||||
| Operating Cash Flow | -32,694 | -22,962 | -13,365 | -61,289 | -46,859 |
| Capital Expenditure | -72 | N/A | N/A | -41 | -41 |
| Free Cash Flow | -32,766 | -22,962 | -13,365 | -61,330 | -46,900 |